Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuanggen Oral Liquid for Influenza (Heat Toxin Attacking Lung)
CTR20260117Phase 2Active
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shuanggen Oral Liquid in influenza, sponsored by The Fifth Medical Center of the PLA General Hospital. Started Jan 2026; status: active.
02
Drugs
Shuanggen Oral Liquid
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20260117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260117.